Organogenesis Holdings Inc (ORGO) — Financial Flexibility Index
Organogenesis Holdings Inc (ORGO) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of $5.31 Million (operating CF $3.08 Million minus capex $2.23 Million) represents 0% of total liabilities ($123.85 Million). Also explore net asset growth rate of Organogenesis Holdings Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Organogenesis Holdings Inc Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Organogenesis Holdings Inc across 11 annual periods. Check how strategically is Organogenesis Holdings Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Organogenesis Holdings Inc (2001–2024)
Year-by-year free cash flow to debt coverage for Organogenesis Holdings Inc. For the full company profile including market capitalisation, see ORGO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.22x | $24.24 Million | $14.21 Million | $112.57 Million | ▼ -29.4% |
| 2023 | 0.30x | $55.28 Million | $30.92 Million | $181.36 Million | ▼ -4.7% |
| 2022 | 0.32x | $58.76 Million | $24.86 Million | $183.69 Million | ▼ -30.7% |
| 2021 | 0.46x | $93.20 Million | $61.98 Million | $201.92 Million | ▲ +196.0% |
| 2020 | 0.16x | $23.14 Million | $5.47 Million | $148.41 Million | ▲ +194.3% |
| 2019 | -0.17x | $-27.29 Million | $-33.53 Million | $165.10 Million | ▲ +67.3% |
| 2018 | -0.50x | $-58.88 Million | $-60.74 Million | $116.64 Million | ▼ -505.6% |
| 2017 | 0.12x | $1.84 Million | $-586.60K | $14.78 Million | ▲ +76.5% |
| 2016 | 0.07x | $798.77K | $-562.23K | $11.33 Million | ▲ +100.3% |
| 2015 | -23.25x | $-9.68 Million | $-10.19 Million | $416.43K | ▼ -26063.7% |
| 2001 | -0.09x | $-417.76K | $-1.40 Million | $4.70 Million | — |